NCT05071482 2025-05-01
Flumatinib Versus Imatinib Combined With Chemotherapy for de Novo Ph+ ALL
Institute of Hematology & Blood Diseases Hospital, China
Phase 4 Terminated
Clinical Trials
8 trialsNCT03844360 2025-03-30
Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease
Shandong University
Phase 4 Recruiting
NCT02602314 2022-01-20
SUSTRENIM
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 4 Unknown
NCT01578213 2019-12-03
ISAV
University of Milano Bicocca
Phase 4 Completed
NCT00845221 2016-10-11
Glivec in Pediatric Chronic Myeloid Leukemia (CML)
Poitiers University Hospital
Phase 4 Completed
NCT02894645 2016-09-30
Malaysia-Singapore Acute Lymphoblastic Leukemia 2010 Study
National University Hospital, Singapore
Phase 4 Unknown
NCT01297777 2016-08-29
Imatinib in KIT-negative Systemic Mastocytosis
Hospital Virgen de la Salud
Phase 4 Completed
NCT00390897 2008-11-27
Glivec® (Imatinib Mesylate, STI571) in Monotherapy Versus Glivec®-Interferon Alpha in the Treatment of Chronic-Phase Chronic Myeloid Leukaemia
PETHEMA Foundation
Phase 4 Completed